NEURALINK PATIENT MOUSE CONTROL
Tamil Nadu's TB care initiative records at least 38% reduction in deaths
As part of the study done by ICMR National Institute of Epidemiology (NIE) and Tamil Nadu State TB Cell, the reduction was observed under the Tamil Nadu Kasanoi Erappila Thittam (TNKET), a state-specific programme aimed at making the state TB-death-free, the researchers said.
'Liquid biopsy can ease financial burden for cancer patients': Scientists on how a $1,000 test could save $10,000 in treatment costs
Liquid biopsy, a blood-based test that detects and analyses cancer-related biomarkers, is gaining ground as a tool to monitor disease progression and guide treatment decisions. Scientists Catherine Alix-Panabieres and Klaus Pantel, who coined the term in 2010, spoke to ET about its growing role in cancer care, the potential to reduce treatment costs through personalised medicine, and the need for more clinical trials to establish its benefits for patients.
Arunoday Singh-headed O-Health secures strategic funding
O-Health has received strategic funding from several investors to advance its healthcare technology solutions. The company aims to enhance its voice-first AI-enabled clinical pre-assessment platform for better patient information management. The investment will support the expansion into additional healthcare sectors and development of indigenous AI models and clinical hardware. O-Health plans to broaden its focus to include preventive health technologies and intelligent hospital workflows.
New York reports first measles-linked death in over 30 years: Here's when you should get your child vaccinated against the virus
A child in Lewis County, New York, has died due to a measles infection. This marks the state's first death from measles in over three decades. New York has recorded 178 cases of measles this year, with most cases from outside New York City. The state has declared a measles outbreak emergency amid surging cases.
US hospitals brace for tougher 2027 as coverage losses and Medicaid cuts loom
US hospital operators are experiencing revenue pressure due to an increase in uninsured patients affecting their operating margins. The expiration of federal subsidies is causing ACA exchange premiums to rise sharply, leading to more patients losing coverage. Major hospital chains are bracing for declines in Medicaid supplemental payments that could hit their finances hard. Analysts caution that forthcoming changes to Medicaid requirements might exacerbate issues for hospital operators.
Ex-Ultrahuman executive launches AI ring startup Aina for agentic interactions
The startup said it is positioning the device as an alternative interface to smartphones for everyday interactions with AI systems. It has spent the past 15 months developing the product and is now opening pre-orders globally, with prices starting at $399 (about Rs 36,000), the startup said in a statement.
- Go To Page 1
India, Israel vote against Pak-backed UN arms control resolution: Sources dismiss voting coordination
India has voiced its opposition to a Pakistan-led UN resolution on regional arms control, asserting that arms control transcends regional boundaries. With approximately 180 nations endorsing it, both India and Israel stood alone in dissent. India reiterated its long-standing position on arms control as a matter of principle, while a few other countries, including the U.S., shared hesitations about the resolution.
Aartas CliniShare to add 20,000 sq. ft of co-working space
Aartas CliniShare aims to add 20,000 sq. ft. of healthcare infrastructure across Delhi NCR by the financial year-end. The company is focusing on Noida, West Delhi, and North Delhi for its expansion efforts. Aartas CliniShare operates on a managed OPD infrastructure model to serve various healthcare enterprises.
AI sharpens cat-and-mouse hacking battle as companies strengthen defences
From hacked supermarket fridges and a record cryptocurrency theft at Binance to an emergency over flaws in widely used web software, companies worldwide are facing a wave of cyber threats executives say AI is accelerating
Dr Reddy's Laboratories receives ANVISA approval for generic semaglutide injection in Brazil
Dr Reddy’s Laboratories obtained marketing authorisation from Brazil’s ANVISA for a generic semaglutide injection. The product will be available as a pre-filled, multi-dose pen in two dosages for weekly administration. This drug targets treatment for type 2 diabetes alongside diet and exercise, particularly in patient groups needing alternative therapies. Brazil's diabetes prevalence creates significant market demand, estimated at approximately $244.6 million.
Your old medical reports may reveal a disease risk you don't know about. Here's how AI can help
AI could help uncover hidden health risks by analysing years of old medical reports, blood tests, prescriptions and hospital records. Predictive AI models may identify patterns linked to conditions such as cardiac arrhythmias, liver disease and Type 1 diabetes, potentially allowing earlier medical intervention. However, incomplete medical records, data inconsistencies and false alerts remain major challenges.
Sirolimus-coated balloon shows 8-percentage-point advantage in three-year peripheral artery trial
Patients treated with sirolimus-coated balloons were more likely to remain free from repeat procedures to reopen blocked leg arteries than those receiving paclitaxel-coated balloons, according to three-year results from the SIRONA clinical trial presented at TCT 2026. While both treatments showed similar improvements in walking ability and quality of life, researchers said the findings require confirmation through five-year follow-up.
Trump shares new MAGA-style ‘Veto’ hat as Democrats take control of both House and Senate after midterm elections, days after threatening to become ‘Mr Veto’
Donald Trump shared a photo of a red 'Veto' hat on Truth Social amid the midterm elections. Media projections indicate that Democrats may gain control of both House and Senate. Trump indicated he would become 'Mr. Veto' if Republicans lost control over Congress and mentioned negotiations may occur later. The veto is a significant power for a president, allowing rejection of bills passed by Congress.
Adam Hamilton defeats Trump-backed Roger Marshall in Kansas, ending 94-year Democratic Senate drought
Adam Hamilton achieved a historic victory in Kansas, becoming the first Democrat elected to the US Senate in 94 years. He defeated Trump-backed Republican Roger Marshall in a contest initially deemed safely Republican. Hamilton, who emphasizes affordability and bipartisanship, campaigned effectively amidst a changing political landscape. The race gained attention from notable figures, including Donald Trump and Vice President JD Vance.
Wockhardt seeks 14-year data shield for India-made drugs
Mumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for difficult-to-treat infections. In May this year, the company secured approvals from Indian and US drug regulators for a breakthrough drug, Zaynich (cefepime + zidebactam), to treat complicated urinary tract infection, including acute pyelonephritis or severe kidney infections. Wockhardt has showcased six drugs to treat antimicrobial resistance (AMR).
Stop the price scam in our hospitals
A recent investigation in Maharashtra has shed light on concerning price hikes for medical supplies charged to patients. Items such as IV infusion sets have seen astronomical price increases, exceeding 2,800% over wholesale prices. Regulatory agencies have recognized that they lack jurisdiction over the pricing of medical disposables, amplifying worries about the potential for patient exploitation.
When will we know the US midterm results? What the first numbers won't tell you and will the key races take days?
The first US midterm election results are expected Tuesday evening, but close races could take days to call. Early totals can shift as election officials report more ballots every hour.
His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccines
Hyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technology. Inspired partly by his family's experience with pancreatic cancer, he aims to help the immune system identify and attack cancer cells using treatments designed around individual patients' tumour genetics.
Cancer drug prices fell in 2019 too, but mark-ups of up to 700% are back
The government's latest cancer drug price cuts may offer patients some relief, but the impact could be short-lived. An analysis of medicines covered in the 2019 exercise found that mark-ups had risen to as much as 700% by 2026, raising questions about whether one-time price cuts can keep cancer treatment affordable.
The business of running a hospital: Balancing profitability, patient trust and scale
A hospital’s financial health depends on more than occupancy and revenue, requiring a careful balance of cost control, cash flow and patient trust.
Blood pressure drug recall: FDA flags thousands of bottles after pills fail quality tests; here's what to check
A major recall has been initiated for certain blood pressure medications produced by Macleods Pharma USA. Patients are urged to verify their medications against specific lot numbers and reach out to their pharmacists. The FDA indicates that this recall stems from issues with dissolution specifications. Failure to comply with proper guidelines could pose serious health risks from unmanaged hypertension.
Frontline Workers Know How to Solve Your Organization’s Biggest Problems
Frontline employees often know exactly what’s preventing organizations from performing at their best, yet traditional engagement surveys rarely uncover those insights or translate them into action. Companies can close that gap by adopting a disciplined six-step process that combines structured interviews, targeted surveys, collaborative problem solving, and rapid experimentation. When leaders and frontline employees cocreate solutions—and measure their impact—they improve trust, strengthen engagement, and design work that delivers better outcomes for employees, customers, and the business
UC innovations make TIME’s Best Inventions of 2026: How a pancreatic cancer drug and smarter wheelchair are changing lives?
From a pancreatic cancer drug that targets KRAS mutations to a smarter power wheelchair, University of California research is reaching beyond laboratories. Daraxonrasib, developed from discoveries at UCSF, received FDA approval in August. Meanwhile, UC Berkeley alumnus Tony Hong’s Strutt ev¹ uses sensors and voice controls to make everyday mobility easier.
Hospital balance sheet: How AI could cut costs and improve efficiency
As hospitals grapple with soaring costs in drugs, supplies, and labor, the integration of AI emerges as a vital necessity.
Sun Pharma ordered to halt eye drug production at Assam plant over quality lapses: Report
Indian regulators have ordered Sun Pharmaceutical Industries to stop manufacturing ophthalmic products at the Assam facility. This decision followed the discovery of failures in the company's quality management system. A joint inspection cited lapses that affected drug safety and quality, leading to a recall of several eye-drop brands. Significant adverse cases have raised concerns regarding product contamination, prompting further investigation.
NPPA list brings little relief: No price cut for 25% cancer drugs
Nearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across 643 packs is 38.22%. Several high-cost patented medicines remain unchanged, prompting patient advocates to question how much relief the trade-margin cap will actually deliver when the new prices take effect on November 9.
India’s drug pricing policy must balance affordability, medicine availability and pharma industry growth
The Government of India has recently capped trade margins on anti-cancer medicines at 30%. This decision has reignited the ongoing discussion about drug pricing and accessibility. The existing regulatory framework aims to provide affordable medicines while supporting the pharmaceutical industry. Ensuring pricing transparency and targeted interventions can help address excessive margins in the supply chain. The ultimate goal remains to enhance patients' access to quality medicines at reasonable prices.
Anti-cancer medicines: How to protect the patient today without weakening India's healthcare capacity for tomorrow
India should examine trade margins across medicines, medical devices and consumables using a common, scientifically credible method - not a one-size-fits-all formula - to identify where and how intervention is needed. Meaningful stakeholder consultation must form part of this exercise to help design a framework that is both effective and workable. It can ensure that unjustified margins are addressed while recognising legitimate differences in clinical settings, infrastructure, safety requirements, geographical reach and the cost of delivering quality care.
Doctors in 2005 gave a Colorado woman weeks to live; she fought back, and in 2015, she built a free art programme for cancer patients
Being diagnosed with cancer is life-changing. The devastation can destroy the self-esteem of many. However, for one woman in Colorado, this diagnosis did not end her zest for life but gave her the initiative to launch a programme to help fellow cancer survivors with art.
Load More
